February marks a milestone

We’re celebrating five years of Swizzard!

Swizzard was founded at the beginning of 2021 with a clear ambition: to help bring medical breakthroughs to Swiss patients. Today, we’re proud of what we’ve achieved thanks to our innovative clients and an exceptional team. 

Together, we’ve helped 39 biotech companies establish and grow their Swiss presence, advancing innovations across oncology, metabolism, dermatology, neurology and beyond, with a strong focus on rare diseases. 

Along the way, we’ve contributed to bringing numerous medicines, including trailblazing ATMPs, to the Swiss market. And we’ve helped hundreds of Swiss patients gain access to innovative therapies through article 71 KVV. 

Over the past five years, we’ve built a dedicated management team and covering the full spectrum of expertise needed for success in the Swiss market:  

Bettina Schelbert, Commercial 

Karin Senn, Medical 

Annabelle Müller, Market Access 

Philipp Heider, Medical & Market Access 

Isabelle Zürcher, Business Support Lead  

As we reflect on this important milestone, we’re not just celebrating what Swizzard does but also how we do it: with trust, collaboration, curiosity and a shared commitment to helping patients.

Thank you to everyone who has been part of this journey. We’re excited for what comes next!